MD Anderson
- United States
Boehringer Ingelheim and MD Anderson Expand Collaboration to Accelerate Development of KRAS and TRAILR2 Compounds in Lung Cancer
Ingelheim, Germany & Houston, United States: Boehringer Ingelheim and The University of Texas MD Anderson Cancer Center today announced the…
Read More »